Adjunctive use of oral MAF is associated with no disease progression or mortality in hospitalized patients with COVID-19 pneumonia: The single-arm COral-MAF1 prospective trial

Author:

Spadera Lucrezia,Lugarà Marina,Spadera Maria,Conticelli Mariano,Oliva Gabriella,Bassi VincenzoORCID,Apuzzi Valentina,Calderaro Francesco,Fattoruso Olimpia,Guzzi PietroORCID,D’Amora Maurizio,Catapano Oriana,Marra Roberta,Galdo Maria,Zappalà Michele,Inui Toshio,Mette MartinORCID,Vitiello Giuseppe,Corvino Maria,Tortoriello Giuseppe

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference99 articles.

1. The novel coronavirus outbreak in Wuhan, China;Zhu;Glob. Health Res Policy,2020

2. World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19);Sohrabi;Int J. Surg.,2020

3. New challenges to fighting COVID-19: Virus variants, potential vaccines, and development of antivirals;Chen;Biosci. Trends,2021

4. Chen J., Wang R., Gilby N.B., et al. Omicron (B.1.1.529): Infectivity, vaccine breakthrough, and antibody resistance. ArXiv. 2021 Dec 1:arXiv:2112.01318v1. Preprint.

5. Natural history of COVID-19 and therapeutic options;Gautret;Expert Rev. Clin. Immunol.,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3